Withdrawal of a drug from the market: what should the prescriber do?

JAMA. 1994 Oct 26;272(16):1253.

Authors

D Ross-Degnan, S B Soumerai, E E Fortess, J H Gurwitz

PMID: 7933365

No abstract available

Publication types

Comment
Letter

MeSH terms

Drug Approval*
Drug Utilization*
Product Surveillance, Postmarketing*
United States
United States Food and Drug Administration